G.O.T. Therapeutics GmbH

G.O.T. Therapeutics GmbH is a biotechnology company developing liposomal systems for the delivery of genetic material and cytostatic drugs. G.O.T. Therapeutics was founded in July 1997 as a spin-off from the MDC Berlin-Buch campus. In February 2000, the company established a partnership with functional genomics company Atugen AG to develop new lipid formulations to enhance the delivery of Atugen’s GeneBloc™ molecules.